Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec appointment
confidence 85%
filed 2026-07-02
Item 5.02
The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC (the sponsor) on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-02
Item 5.02
The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC (the sponsor) on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 94%
filed 2026-07-02
Item 5.02
Six Flags appointed Mark Pauls as Chief Operating Officer effective July 15, 2026, succeeding Tim Fisher. Pauls' compensation package includes a $600,000 base salary and $1,560,000 annual equity grant target, with comprehensive severance provisions.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-02
Item 5.02
The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC (the sponsor) on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as it affects the registrant's principal financial officer and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-02
Item 5.02
The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC (the sponsor) on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-02
Item 5.02
The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the appointment of two named executives to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-02
Item 5.02
The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC (the sponsor) on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-02
Item 5.02
The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-02
Item 5.02
The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC (the sponsor) on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-02
Item 5.02
The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC (the sponsor) on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-02
Item 5.02
The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the appointment of two named executives to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-01
Item 8.01
Andrew D. Walker has been promoted to Executive Vice President, Chief Customer Operations Officer, representing a material elevation in title and scope of responsibility within the company's executive leadership. The disclosure emphasizes his expanded portfolio of operational and transformation functions, making this a significant executive appointment that would affect a reasonable investor's assessment of the company's leadership structure and operational direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
Williams Companies appointed two independent directors, Robb E. Turner and Lloyd W. (Billy) Helms, Jr., to its Board of Directors effective July 1, 2026, expanding the Board from ten to twelve members. Both appointees will receive annual compensation of $130,000 in cash retainer and $200,000 in RSU equity retainer.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-01
Item 5.02
Rocco F. Arcuri, Sr. was appointed as a director of Arrow Financial Corporation and as Senior Vice President, Regional President, Mohawk Valley of Arrow Bank, effective July 1, 2026, following the completion of the Adirondack acquisition. The appointment reflects leadership integration from the acquired entity.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-01
Item 5.02
Nathan E. Baxter was appointed President & Chief Executive Officer effective June 26, 2026, and elected to the Board of Directors. While the filing also discloses James Hagedorn's departure as CEO and Chairman (and his severance arrangements), the principal disclosed action centers on Baxter's appointment to the top executive role and board seat, which is the forward-looking leadership change. The appointment is material as it represents a significant succession event at the company's helm after Hagedorn's 25-year tenure as CEO.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
The Board appointed Damian A. Ribar as Executive Vice President and Chief Operating Officer, effective July 20, 2026. While the disclosure includes compensatory details (base salary of $500,000, equity awards, and bonus eligibility), the principal disclosed action is the appointment of a named executive officer to a C-suite role. The compensation terms are ancillary to the appointment itself.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-01
Item 7.01
Ramesh Srinivasan was appointed to the executive officer position of Executive Vice President, Chief Strategy Officer, effective August 1, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
The filing discloses the appointment of Bruce Hausmann as a director of Mativ Holdings, effective July 1, 2026, to fill a newly created board vacancy. The Board increased from 6 to 7 members and appointed Hausmann as a Class I director with a term expiring at the 2029 Annual Meeting. He was also appointed to the Audit Committee and qualifies as an "audit committee financial expert." This is a clear executive appointment event, material to investors as it affects board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-01
Item 5.02
The disclosure centers on the appointment of Alison L. Hannah, M.D. as Executive Vice President and Chief Medical Officer of Rigel Pharmaceuticals, effective July 1, 2026. While the filing also mentions Dr. Hannah's concurrent resignation from the Board and the departure of the prior CMO, Lisa Rojkjaer, the principal action disclosed is the appointment of a named executive officer to a C-suite position. This is material to investors as it affects the Company's senior leadership and medical strategy.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
The filing discloses the appointment of Nnamdi Njoku as President of Omnicell, effective July 1, 2026, while retaining his COO role. Although the disclosure also mentions that Randall Lipps stepped down from the President role, the principal action disclosed is Njoku's appointment and promotion to President. The filing emphasizes his expanded responsibilities in shaping long-term growth strategy and operational execution, and includes a material equity award of approximately $500,000 in restricted stock units as part of the promotion.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-07-01
Item 5.02
QXO appointed Alec Covington as a director effective upon completion of the TopBuild Merger and appointed Madeline Otero as Interim Chief Accounting Officer effective July 1, 2026, with specified compensation including $400k base salary, $600k equity target, and $500k retention award.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-01
Item 5.02
The disclosure centers on John Vong's appointment as Senior Vice President – Accounting and his succession to the principal accounting officer role effective August 7, 2026, following Glenn Sobotka's retirement. While both a departure and appointment occur, the filing emphasizes Vong's appointment and qualifications, making the appointment the principal disclosed action. The change in the principal accounting officer is material to investors assessing the company's financial reporting oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
Uwe Breitweg, Vice President Powertrain, Emission and Battery Strategy of the BMW Group, was appointed as a Class III director of Solid Power effective July 1, 2026, pursuant to BMW Holding's director nomination rights. The appointment is material given Breitweg's two decades of automotive leadership, deep battery strategy expertise, and BMW's role as a key development partner.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-07-01
Item 5.02
Effective July 1, 2026, Mobility Global appointed a substantially reconstituted board of seven new directors (Eric W. Aboaf, William W. Eager, Heather Lavallee, Monique F. Leroux, Mark S. Peek, Shilpa Ranganathan, and Alexander Taussig), appointed Joseph R. Hinrichs as Chair, and appointed three new officers: Scott Fredericks as President of CARFAX, Joseph S. LaFeir as President of Mobility Business Solutions, and Renato Negro as Chief Accounting Officer. These appointments reflect the company's transition to independent public company status following its separation from S&P Global.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-01
Item 5.02
The filing discloses both a director departure (Alexandra Herger's resignation effective July 1, 2026) and a director appointment (John Maxwell appointed to succeed her on the same date). While both events occur, the principal disclosed action centers on the appointment of Maxwell as a director and member of the Nominating and Governance Committee, with nomination for a full 3-year term. The appointment is the forward-looking governance action that materially affects board composition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-01
Item 5.02
Robert R. Franklin, Jr. was appointed as a director and Vice Chairman of Prosperity and Prosperity Bank effective upon completion of the Stellar merger on July 1, 2026, with a three-year employment agreement providing $1.12M base salary, 175% bonus target, $3M signing bonus, 25,000 RSA award, and severance protections.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 7.01
The filing discloses the appointment of Thomas Addis as Chief Revenue Officer of Sprinklr, effective July 1, 2026, reporting to the CEO. This is a material executive appointment at the C-suite level. The press release emphasizes his extensive go-to-market and revenue leadership experience across high-growth enterprise technology companies, indicating this is a significant leadership change intended to drive growth and execution.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-07-01
The 6-K discloses the appointment of Brandon Craig as Chief Executive Officer and Executive Director of BHP Group Limited, effective 1 July 2026. The filing furnishes an Initial Director's Interest Notice detailing Craig's shareholdings and equity interests upon taking office. This is a material executive appointment at the C-suite level of a major multinational mining company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
The filing discloses the appointment of Alfred F. Kelly, Jr. to Prologis' board of directors on June 29, 2026. Kelly is a prominent executive with significant leadership experience (former CEO of Visa, president of American Express) and currently serves on the board of General Motors. The appointment of a director with this caliber of experience and external board responsibilities is material to investors assessing the company's governance and strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-01
Item 5.02
ExxonMobil completed a comprehensive leadership transition effective at the Effective Time of the redomiciliation merger, with 12 directors resigning and 3 new directors (Neil A. Chapman, Neil A. Hansen, Jack P. Williams, Jr.) being elected, plus appointment of new named executive officers including James R. Chapman as President and Treasurer and Susan E. Buchanan as Vice President and Controller.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
John R. Linker was appointed as Executive Vice President of Finance and Chief Financial Officer effective July 1, 2026, succeeding Gregory P. Rustowicz. The appointment includes a base salary of $600,000, a 70% target bonus, and 165% long-term equity incentive participation. Thomas Oddo was also promoted to Chief Accounting Officer with an associated equity increase.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-07-01
Item 5.02
The filing discloses both a director resignation (Andrew Levin) and the election of a new director (Breanna O'Reilly, Ph.D.) on the same date. While both events are present, the principal action emphasized in the disclosure is Dr. O'Reilly's election to the Board effective immediately, with detailed information about her compensation package (70,284 option grant at $13.36/share, $40,000 annual cash retainer, and future equity grants). The appointment is the forward-looking event and receives substantially more disclosure than the departure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-01
Item 5.02
Ravi Thanawala was appointed as Executive Vice President and Chief Financial Officer effective August 3, 2026, with a compensation package including $1M base salary, $2.5M in target equity grants, and a $1M sign-on bonus. Michael Mathias transitioned to a non-officer Strategic Advisor role.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
Maurice Tulloch was appointed to the Board of Directors of Reinsurance Group of America, effective July 1, 2026. Tulloch is the former CEO of Aviva Group and brings extensive executive and operational expertise to strengthen the Board's oversight and global perspective.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-07-01
The 6-K discloses the appointment of Mr. Gang Liu as Chief Financial Officer of Chanson International Holding, effective immediately on June 26, 2026. While the report also mentions Ms. Jihong Cai's resignation as CFO on the same date, the principal disclosed action is the appointment of a named executive to a C-suite officer role. The filing includes Mr. Liu's extensive 30+ years of accounting and financial management experience and references employment and indemnification agreements, consistent with a material executive appointment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
Inogen appointed Andrew Reding as Executive Vice President and Chief Operating Officer, a newly created C-suite role effective July 6, 2026. The appointment includes compensatory arrangements comprising a base salary of $500,000, a 70% bonus target, a $100,000 sign-on bonus, and 130,000 RSUs vesting over three years, approved under Nasdaq Listing Rule 5635(c)(4).
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
Stephanie C. Bush was elected to the Board of Directors of Employers Holdings, Inc. on June 25, 2026, with her term commencing July 1, 2026, increasing board size to nine members. Her appointment reflects her extensive insurance leadership background and expertise in underwriting, product, and distribution.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-07-01
Item 5.02
The filing discloses the election of two new directors (Diya Jolly and Michael Yang) to the Board effective June 29, 2026, along with significant governance changes including the appointment of Shane Trigg as Chairman and Winifred Webb as Lead Independent Director. While the section also includes the retirement of two long-serving directors (Andreas von Blottnitz and Janet Kerr), the primary focus and substantive action centers on the appointment of new directors and restructuring of board leadership roles, making exec_appointment the most salient classification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
The filing discloses the election of George M. Ristau, Jr. to the Board of Directors on July 1, 2026, filling a vacancy created by the passing of James A. Lentz, and his concurrent appointment to the Audit Committee. While the section mentions the departure context (death of Lentz), the principal disclosed action is the appointment of a new director and committee member, making exec_appointment the most salient classification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02 discloses the appointment of Joshua Girnun to Nova Minerals' Board of Directors as a Class I director, effective July 1, 2026. The Board expanded from five to six directors to accommodate this appointment. The press release emphasizes Girnun's significant institutional finance and technical resource background from JP Morgan, positioning him as a key addition during the company's transition to production. This is a material governance event affecting board composition and strategic oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
The filing discloses the appointment of Chris Janis as a member of the Board of Directors, Chairperson of the Audit Committee, and member of the Compensation Committee on July 1, 2026. Item 5.02 explicitly covers this appointment, and the press release emphasizes his 35+ years of financial and governance expertise from PwC and prior CFO roles. This is a material governance event affecting board composition and oversight structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
X4 Pharmaceuticals appointed Kelly Gold as a Class II director effective July 1, 2026, increasing the board size from five to six directors. Ms. Gold, an experienced CFO with prior roles at Biogen and Deutsche Bank, was also appointed to the Audit Committee as an independent director.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
The Board of Directors appointed Ali Keshavarz as a director effective June 26, 2026, expanding the Board from eleven to twelve members. This is a clear executive appointment of a named individual to a director position. While the disclosure also mentions standard director compensation, the principal disclosed action is the appointment itself, not a compensatory arrangement. Keshavarz's background in AI and advanced analytics at CVS Health is highlighted as strategically relevant to the company's growth strategy.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
Terra Grantham was appointed as Chief Financial Officer of CPI Card Group Inc. effective June 29, 2026, after serving as Interim CFO since February 2026. The appointment includes compensatory arrangements comprising a base salary of $450,000, short-term and long-term incentive targets, and a $300,000 RSU grant.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
The filing discloses the Board's approval of Dr. Wah Shing Lam's appointment as an Executive Director of ModuLink Inc., effective July 1, 2026. Dr. Lam, currently serving as Chief Technology Officer, is being elevated to the Board. This is a clear executive appointment event where the principal disclosed action is a person taking on a new role (Board membership), even though he retains his existing CTO position. The appointment is material as it affects the composition of the Company's leadership and Board governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
Dynatrace appointed two new directors to its Board of Directors, effective June 30, 2026: George Riedel (Class I) and Dan Streetman (Class II). The appointments follow constructive engagement with activist investor Starboard Value LP and represent a material governance change, with both appointees bringing significant technology and operational expertise relevant to the company's strategy.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-30
Item 5.02
Kenneth M. Hartwick, former CEO and CFO of Ontario Power Generation, was elected to PPL Corporation's Board of Directors effective July 1, 2026, and assigned to the People and Compensation Committee and Finance Committee.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-30
Item 5.02
The filing discloses both the retirement of Patrick Farrell as CFO and the resignation of Dana Staggs as President, but centers on the appointment of Katherine Jones as Chief Financial Officer effective June 30, 2026. While two departures occur, the principal affirmative action disclosed is Jones's appointment to a key executive role, supported by the press release emphasizing her qualifications and the Board's confidence in her capabilities. The appointment of a new CFO is material to investors assessing management continuity and operational leadership.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-06-30
The Board approved the re-appointment of Ms. Vibha Paul Rishi as an Independent Director for a second term commencing January 23, 2027 through December 31, 2028, subject to shareholder approval. Although technically a re-appointment rather than an initial appointment, this constitutes an executive appointment under Item 5.02 as it is the principal action disclosed—a director taking a role for a new term. The disclosure includes her qualifications, board experience, and independence confirmation as required by SEBI Listing Regulations.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-30
Item 5.02
The Board appointed Matthew Pauls as a Class I director on June 29, 2026, increasing the Board size from seven to eight members. While the disclosure includes compensatory details (stock option grant of 6,000 shares), the principal disclosed action is the appointment of a new director with substantial industry experience in biopharmaceuticals. This is a governance event centered on a person taking a role, making exec_appointment the most salient classification.
View raw filing on EDGAR →